Thromboembolic complications related to the use of bone cement during total hip arthroplasty - Pathogenesis and prophylaxis;Thromboembolische komplikationen bei der verwendung von knochenzement in der hüftendoprothetik - Pathogenese und prophylaxe

Zeitschrift fur Orthopadie und Ihre Grenzgebiete

Volumn 139, Issue 3, 2001, Pages 221-228

  Heisel, C ^a   Clarius, M ^a   Schneider, U ^a   Breusch, S J ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Bone cement; Cementing technique; Complications; Thromboembolism; Total hip arthroplasty

Indexed keywords

BONE CEMENT;

ARTICLE; CARDIOVASCULAR RISK; HUMAN; IMPLANTATION; LAVAGE; SHEAR RATE; SURGICAL TECHNIQUE; THROMBOEMBOLISM; TOTAL HIP PROSTHESIS;

ARTHROPLASTY, REPLACEMENT, HIP; BONE CEMENTS; EMBOLISM, FAT; HUMANS; IRRIGATION; RISK FACTORS; THROMBOEMBOLISM;

EID: 0034914883     PISSN: 00443220     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-16325     Document Type: Article

References (107)

1. Effect of cement pressure and bone stength on polymethylmethacrylate fixation
2. The results of improved cementing techniques for total hip arthroplasty in patients less than fifty years old
3. Improved cementing techniques and femoral component loosening in young patients with hip arthroplasty
4. Dihydroergotamin/heparin in the prevention of deep vein thrombosis after total hip replacement
5. Anaphylatoxin release in association with methylmethacrylate fixaton of hip prostheses
6. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement
7. Comparison of real-time B-mode ultrasonography and bilateral ascending phlebographie for detection of postoperative deep vein thrombosis following electice hip surgery
8. Experimental production of vascular hypotension and bone marrow and fat embolism with methylmethacrylate cement
9. Vacuum application of bone cement in total hip arthroplasty
10. Der stand der zementiertechnik bei hüfttotalendoprothesen in Deutschland
11. Einfluß der zementiertechnik auf das zementierergebnis am coxalen femurende
12. Verminderung des fettembolierisikos in der zementfreien hüftendoprothetik durch die verwendung der gepulsten druckspülung
13. Serum analysis and toxic effects of methylmethacrylate
14. Long-term comparison of Charnley and Stanmore design total hip replacements
15. High-volume, high pressure pulsatile lavage during cemented arthoplasty
16. Echocardiography of transatrial embolism during cemented and uncemented hemiarthroplasty of the hip
17. Medullary lavage reduces embolic pheneinmena and cardiopulmonary changes during cemented hemiarthroplasty
18. Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty
19. Evidence for induction of cardiorespiratory and vascular complications by methylmethacrylate moneinmer in hip replacement surgery. Laboratory and animal investigations
20. Prolonged thrombo prophylaxis following hip replacement surgery - Results of a double-blind, prospective, randomised, placebo-controlled study with dalteparin (Fragmin)
21. Fat embolism following prosthetic replacement of the femoral head
22. Deep vein thrombosis after total hip replacement
23. Modern cementing techniques. An experimental study of vacuum insertion of bone cement
24. The role of methylmethacrylate monomer in the formation and haemodynamic outcome of pulmonary fat emboli
25. Prevention of deep-vein thrombosis and pulmonary embolism, after total hip replacement. Comparison of molecular-weight heparin and unfractionated heparin
26. Prevention of thromboembolic disease after elective surgery of the hip
27. Lower risk of thromboembolic disease after total hip replacement with non-cemented than with cemented prostheses
28. Fatal pulmonary embolism after total hip replacement
29. Anaesthetic techniques and thromboembolism in total hip arthroplasty
30. Cardiac arrest and bone cement
31. Cardiac arrest and bone cement
32. The shear strength of trabecular bone from the femur, and some factors affecting the shear strength of the cement-bone interface
33. Current attitudes to cementing techniques in British hip surgery
34. Modifizierte operationstechniken zur reduzierung der knochenmarksausschüttung in der zementfreien hüftendoprothetik
35. In vivo femoral intramedullary pressure during uncemented hip arthroplasty
36. A histologic and hemodynamic study of the toxic effects of monomeric methylmethacrylate
37. Some physiological aspects of prosthesis stabilization with acrylic polymer
38. A meta-analysis of methods to prevent venous thromboembolism following total hip replacement
39. Femoral intramedullary pressure during in vitro cemented and cementless total hip arthroplasty
40. Pulmonary embolism and its prophylaxis following the Charnley total hip replacement
41. Deep venous thrombosis following Charnley arthroplasty
42. Die prophylaxe der postoperativen, venösen thromboembolie beim hüftgelenksersatz mit heparin und dihydroergotamin
43. Heparin and dihydroergotamine prophylaxis against thrombo-embolism after hip arthroplasty
44. Intramedullary pressure and pulmonary embolism of femoral medullary contents in dogs during insertion of bone cement and a prosthesis
45. Intraoperative death associated with acrylic bone cement
46. The chemical composition of the fat emboli in the post-absorptive dog
47. Efficacy and safety of prolonged thromboprophylaxis with a low molecular weight heparin (dalteparin) after total hip arthroplasty - The Danish Prolonged Prophylaxis (DaPP) Study
48. Some studies of the complement system during total hip replacement using bone cement under general anaesthesia
49. Zur anwendung von heparin in kombination mit dihydroergotamin zur postoperativen thromboseprophylaxe bei hüftgelenkoperationen
50. Medikamentöse thromboembolieprophylaxe in der elektiven hütchirurgie unter berücksichtigung thrombophiler zustände
51. Blood pressure and bone cement
52. Penetration and shear strength of cement-bone interfaces in vivo
53. Cement penetration with pulsed lavage versus syringe lavage in total knee arthroplasty
54. Bone surface preparation in cemented joint replacement
55. Progneinsis of total hip replacement in Sweden: Revision and re-revision rate in THR
56. Tödliche, intraoperative lungenfettembolie bei endoprothese des hüftgelenkes
57. Cement pressurisation during hip replacement
58. Blood clearance and acute pulmonary toxicity of methylmethacrylate in dogs after simulated arthroplasty and intravenous injection
59. Hazards of acrylic bone cement - A report of two cases
60. Methylmethacrylate bone cement does not release histamine in patients undergoing prosthetic replacement of the femoral head
61. Thromboembolism after total hip replacement: Role of epidural and general anesthesia
62. Thromboembolism following hip fracture
63. The effect of improved cementing techniques on component loosening in total hip replacement. An 11-year radiographic review
64. Thromboprophylaxis and death after total hip replacement
65. Deep vein thrombosis after total hip replacement: A clinical and phlebographic study
66. Graded pressure stockings in prevention of deep vein thrombosis following total hip replacement
67. Cardiopulmonary function and pulmonary microemboli during arthroplasty using cemented or non-cemented components: The role of intramedullary pressure
68. Sudden death during primary hip arthroplasty
69. Cardiac arrest during hip arthroplasty with a cemented long stem component
70. Cardiovascular effects of methylmethacrylate cement
71. Cardiovascular effects of acrylic bone cement in rabbits and cats
72. Cardiovascular effects of implanted acrylic bone cement
73. Cardiovascular effects of implanted acrylic cement
74. The John Charnley Award: Prophylaxis of fat and bone marrow embolism in cemented total hip arthroplasty
75. Comparison of fixation of the femoral component without cement and fixation with use of a bone-vacuum cementing technique for the prevention of fat embolism during total hip arthroplasty. A prospective, randomized clinical trial
76. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement: Double-blind randomised comparison of enoxaparin versus placebo
77. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial
78. Anasthésie-réanimation chez le sujet âgé en traumatologie
79. New clinico - Pathophysiological studies on the bone cement implantation syndrome
80. Pathogenesis of circulatory reactions triggered by nervous reflexes during the implantation of bone cements
81. Sind intraoperative kreislaufkomplikationen bei alloarthroplastiken des hüftgelenksdurch methylmethacrylat bedingt
82. Mechanisms of cardiopulmonary disturbances during total hip replacement
83. Lebensbedrohliche sofortkomplikationen durch fettembolie nach einsetzen von totalendoprothesen mit polymethylmethacrylat
84. The outcome of Charnley total hip arthroplasty with cement after a minimum twenty-year follow-up. The results of one surgeon
85. Elective total hip replacement: Incidence, emergency readmission rate, and postoperative mortality
86. Perioperative risiken und probleme beim totalhüftgelenksersatz
87. The role of lavage in preventing hemodynamic and blood-gas changes during cemented arthroplasty
88. Zur totalendoprothese bei der schenkelhalsfraktur des alten menschen - Fine analyse von 284 fällen
89. An in vitro study of femoral intramedullary pressures during hip replacement using modern cement technique
90. Femoral vein thrombosis and total hip replacement
91. Spinal and general anaesthesia in total hip replacement: Frequency of deep vein thrombosis
92. Elevation of intramedullary pressure when methylmethacrylate is inserted in total hip arthroplasty
93. Histaminfreisetzung und kardiovaskuläre reaktionen nach implantation yon knochenzement bei totalem hüftgelenkersatz
94. Thromboembolische komplikationen und ihre prophylaxe beim hüftgelenkersatz
95. The chemical composition of circulating fat emboli released during total hip prosthesis
96. Untersuchungen zur höhe und bedeutung des intramedullären Druckes während des einzementierens von hüftendoprothesen
97. Pharmacokinetics of methylmethacrylate monomer during total hip replacement
98. Pathogenesis and prophylaxis of circulatory reactions during total hip replacement
99. Hypotension during cemented arthroplasty. Relationship to cardiac output and fat embolism
100. Prevention of thromboembolism following elective hip surg
101. 15-21-Year results of the Charnley low-friction arthroplasty
102. Charnley low-friction arthroplasty: A study of results in young patients
103. Embolien aus dem knochenmarkskanal nach einsetzen von intramedullären femurkopfendoprothesen mit polymethylmethacrylat
104. Multimorbidität und perioperatives risiko der hüftgelenktotalendoprothetik (HTEP)